✦ LIBER ✦

DCEP for relapsed or refractory multiple myeloma after therapy with novel agents

✍ Scribed by Park, Silvia; Lee, Su Jin; Jung, Chul Won; Jang, Jun Ho; Kim, Seok Jin; Kim, Won Seog; Kim, Kihyun

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Future of Therapy for Relapsed/Refra

✍ Philippe Moreau 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 652 KB

Combination Therapy with Thalidomide, In

✍ Naoya Ochiai; Noriko Yamada; Ryo Uchida; Shin-ichi Fuchida; Akira Okano; Mayumi 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 86 KB

Emerging therapies for the treatment of

✍ Meletios A. Dimopoulos; Jesus F. San-Miguel; Kenneth C. Anderson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Safety of prolonged therapy with bortezo

✍ James R. Berenson; Sundar Jagannath; Bart Barlogie; David T. Siegel; Raymond Ale 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

Patterns of Relapse or Progression After

✍ Ahn, Jae-Sook; Jung, Sung-Hoon; Yang, Deok-Hwan; Bae, Soo-Young; Kim, Yeo-Kyeoun 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 343 KB

Thalidomide with or without dexamethason

✍ Raymond Alexanian; Donna Weber; Athanasios Anagnostopoulos; Kay Delasalle; Micha 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 150 KB